The effect of vascular endothelial growth factor taking tube shunt for neovascular glaucoma

The effect of vascular endothelial growth factor taking tube shunt for neovascular glaucoma - The effect of VEGF taking tube shunt for NVG

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018407

Enrollment

Registered

2015-07-25

Start date

2015-07-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neovascular glaucoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The diagnosis of neovascular glaucoma IOP higher than 21mmHg under full doze medication Indication of tube shunt The patient taking informed consent

Exclusion criteria

Exclusion criteria: S.L(-) The past history of any glaucoma operation The past history of any glaucoma except NVG The past history of anti VEGF therapy within one month The past history of constitutional symptom

Design outcomes

Primary

Measure	Time frame
the concentration of aqueous humor VEGF	—

Secondary

Measure	Time frame
intra ocular pressure visual acuity	—

Countries

Japan

Contacts

Public ContactInazaki Hiroshi

Yokohama City University Center Hospital the department of opthalmology

ojionobao@yahoo.co.jp045-261-5656

Outcome results